| Original language | English (Ireland) |
|---|---|
| Media of output | Other Item |
| Volume | 173 |
| Publication status | Published - 1 Apr 2016 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 Years and older with treatment-naive (TN) CLL SLL (RESONATE-2 (TM))
- Michael O'Dwyer
Research output: Other contribution (Published) › Other contribution